Acinetobacter baumannii is an emerging multidrug-resistant pathogen and very little information is available regarding its imipenem resistance in Latin American countries such as Bolivia. This study investigated the antimicrobial resistance profile of 46 clinical strains from different hospitals in Cochabamba, Bolivia, from March 2008 to July 2009, and the presence of carbapenemases as a mechanism of resistance to imipenem. Isolates were obtained from 46 patients (one isolate per patient; 30 males,16 females) with an age range of 1 day to 84 years, and were collected from different sample types, the majority from respiratory tract infections (17) and wounds (13). Resistance to imipenem was detected in 15 isolates collected from different hospitals of the city. These isolates grouped into the same genotype, named A, and were resistant to all antibiotics tested including imipenem, with susceptibility only to colistin. Experiments to detect carbapenemases revealed the presence of the OXA-58 carbapenemase. Further analysis revealed the location of the blaOXA-58 gene on a 40 kb plasmid. To our knowledge, this is the first report of carbapenem resistance in A. baumannii isolates from Bolivia that is conferred by the OXA-58 carbapenemase. The presence of this gene in a multidrug-resistant clone and its location within a plasmid is of great concern with regard to the spread of carbapenem-resistant A. baumannii in the hospital environment in Bolivia.
BertiniA., GiordanoA., VaresiP., VillaL., ManciniC., CarattoliA.2006; First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob Agents Chemother 50:2268–2269 [View Article][PubMed]
CoelhoJ., WoodfordN., Afzal-ShahM., LivermoreD.2006; Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 50:756–758 [View Article][PubMed]
GallegoL., TownerK. J.2001; Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 50:71–77[PubMed]
LeeK., LimY. S., YongD., YumJ. H., ChongY.2003; Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41:4623–4629 [View Article][PubMed]
MendesR. E., BellJ. M., TurnidgeJ. D., CastanheiraM., JonesR. N.2009; Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 63:55–59 [View Article][PubMed]
PapaA., KoulouridaV., SouliouE.2009; Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital. Microb Drug Resist 15:257–260 [View Article][PubMed]
PoirelL., MarquéS., HéritierC., SegondsC., ChabanonG., NordmannP.2005; OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 49:202–208 [View Article][PubMed]
PoirelL., NaasT., NordmannP.2010; Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 54:24–38 [View Article][PubMed]
RobledoI. E., AquinoE. E., SantéM. I., SantanaJ. L., OteroD. M., LeónC. F., VázquezG. J.2010; Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 54:1354–1357 [View Article][PubMed]
RossiF., GarcíaP., RonzonB., CurcioD., DowzickyM. J.2008; Rates of antimicrobial resistance in Latin America (2004–2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis 12:405–415 [View Article][PubMed]
SaderH. S., JonesR. N., GalesA. C., SilvaJ. B., PignatariA. C.SENTRY Participants Group (Latin America)2004; SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis 8:25–79 [View Article][PubMed]
SaderH. S., CastanheiraM., MendesR. E., TolemanM., WalshT. R., JonesR. N.2005; Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents 25:57–61 [View Article][PubMed]
SevillanoE., GallegoL., García-LoboJ. M.2009; First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol (Paris) 57:493–495 [View Article][PubMed]
SgambattiS., GalesA. C., SaderH. S.2010; Antimicrobial resistance in Gram-negative bacteria from developing countries. In Antimicrobial Resistance in Developing Countries pp. 249–266 Edited by De J SosaA., ByarugabaD. K., Amábile-CuevasC. F., HsuehP. R., KariukiS., OkekeI. N. New York, Dordrecht, Heidelberg, London: Springer;
SouliM., GalaniI., GiamarellouH.2008; Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13:1–11[PubMed]
TenoverF. C., ArbeitR. D., GoeringR. V., MickelsenP. A., MurrayB. E., PersingD. H., SwaminathanB.1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239[PubMed]
TognimM. C. B., AndradeS. S., SilbertS., GalesA. C., JonesR. N., SaderH. S.2004; Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 8:284–291 [View Article][PubMed]
TurtonJ. F., KaufmannM. E., WarnerM., CoelhoJ., DijkshoornL., van der ReijdenT., PittT. L.2004; A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 58:170–179 [View Article][PubMed]